RTN4 and myeloid sarcoma: In contrast, NogoA+ cell numbers in layers I/II were unaltered in SCD of patients with early MS (38.8 + 16.6 cells/mm2, Fig. 3d) as compared to control and MS NAGM (Fig. 3e).